MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome and thank you for joining MorphoSys Full Year 2023 Results and Business Update Conference Call.
Morphosys Ag (MOR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 1,303,945 | $23,653,562 | +4027% | 0.04% |
| 2. | Carlson Capital Clint Carlson | 950,461 | $17,241,363 | 1.39% | |
| 3. | Tang Capital Management Kevin C. Tang | 800,705 | $14,524,789 | 1.51% | |
| 4. | Slotnik Capital Charles Slotnik | 655,519 | $11,891,115 | 7.3% | |
| 5. | Segantii Capital Simon Sadler | 463,466 | $8,410,686 | 0.54% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 864,600 | $8,559,540 | 0% | |
| 2. | 427,700 | $4,234,230 | 0.01% | |
| 3. | 405,800 | $4,017,420 | 0% | |
| 4. | 401,300 | $3,972,870 | 0.01% | |
| 5. | 361,138 | $3,575,266 | 0% |
News See All
15 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the 15 top performing European stocks so far in 2024.
12 Best Healthcare Stocks For the Long-Term
In this piece, we will take a look at the 12 best healthcare stocks for the long term.
MorphoSys AG (NASDAQ:MOR) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Third Quarter Statement 2023 of MorphoSys.
12 Best German Stocks To Buy Now
In this piece, we will take a look at the 12 best German stocks to buy now.
MorphoSys AG (NASDAQ:MOR) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the MorphoSys Second Quarter and First Half 2023 Financial Results.
MorphoSys AG (NASDAQ:MOR) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the First Quarter Interim Statement 2023 of MorphoSys.
MorphoSys AG (NASDAQ:MOR) Q4 2022 Earnings Call Transcript
Julia Neugebauer: Ladies and gentlemen, good afternoon and good morning.
MorphoSys AG (NASDAQ:MOR) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Third Quarter 2022 Financial Results Conference Call of MorphoSys.
5 Best German Stocks to Buy Now
MorphoSys AG (NASDAQ:MOR) is a commercial-stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer...